UnknownPhase 1NCT03352310

Feasibility and Safety of Umbilical Cord Blood Transfusion in the Treatment of Neonatal Cerebral Ischemia and Anemia

Studying Neonatal hypoxic and ischemic brain injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mononuclear Therapeutics Ltd.
Principal Investigator
Simon Lam, MD
Chinese University of Hong Kong
Intervention
autologous umbilical cord blood (UCB)(biological)
Enrollment
40 enrolled
Eligibility
All sexes
Timeline
20182020

Study locations (1)

Collaborators

Chinese University of Hong Kong · China Spinal Cord Injury Network

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03352310 on ClinicalTrials.gov

Other trials for Neonatal hypoxic and ischemic brain injury

Additional recruiting or active studies for the same condition.

See all trials for Neonatal hypoxic and ischemic brain injury

← Back to all trials